Marshall Wace’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$928K Buy
+257,135
New +$890K ﹤0.01% 2173
2025
Q2
Sell
-315,865
Closed -$1.72M 2954
2025
Q1
$1.72M Sell
315,865
-55,608
-15% -$315K ﹤0.01% 1535
2024
Q4
$1.84M Buy
371,473
+311,841
+523% +$1.63M ﹤0.01% 1473
2024
Q3
$312K Sell
59,632
-225,134
-79% -$1.3M ﹤0.01% 2120
2024
Q2
$1.95M Sell
284,766
-352
-0.1% -$3.22K ﹤0.01% 1386
2024
Q1
$2.93M Sell
285,118
-36,773
-11% -$272K ﹤0.01% 1205
2023
Q4
$2.67M Sell
321,891
-106,695
-25% -$767K ﹤0.01% 1109
2023
Q3
$2.68M Buy
428,586
+298,665
+230% +$1.29M 0.01% 1093
2023
Q2
$565K Buy
+129,921
New +$288K ﹤0.01% 1945
2022
Q1
Sell
-128,119
Closed -$496K 3704
2021
Q4
$496K Buy
128,119
+116,786
+1,030% +$552K ﹤0.01% 2801
2021
Q3
$70K Buy
+11,333
New +$96.7K ﹤0.01% 2918

Other funds holding LFMD

Marshall Wace's LFMD Position: Q1 2026 in Review

Marshall Wace opened a new position in LifeMD (LFMD) in Q1 2026: 257,135 shares worth $928K. The stake represents ﹤0.01% of the portfolio and ranks #2173 among its holdings. This is a return to the name: Marshall Wace previously reported a position in LFMD as recently as Q1 2025.

Marshall Wace first reported a position in LFMD in Q3 2021 and has held it in 11 quarters since. The position peaked at $2.93M in Q1 2024. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Marshall Wace held 257,135 shares of LifeMD worth $928K as of Q1 2026.
  • LifeMD was a new Marshall Wace position in Q1 2026.
  • LifeMD made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2173 holding.
  • Marshall Wace first reported a position in LifeMD in Q3 2021 and has held it in 11 quarters since.
  • Marshall Wace's LifeMD position peaked at $2.93M in Q1 2024.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.